Can you take Nipocalimab with Risa-Bid?
1 drug interaction and 4 additional warnings found for the following 2 drugs:
- nipocalimab
- Risa-Bid (lactobacillus acidophilus)
Drug interactions
Moderate drug interactions
Moderate:
lactobacillus acidophilus nipocalimab
Applies to: Risa-Bid (lactobacillus acidophilus) and nipocalimab
If you are currently being treated or have recently been treated with nipocalimab, you should let your doctor know before using lactobacillus acidophilus. Depending on the dose and length of time you have been on nipocalimab, you may be at risk for developing rare infections from exposure to products containing live bacteria or yeast. Depending on your overall health and medical condition, it may be advisable to avoid using lactobacillus acidophilus until your immune system has recovered from the effects of nipocalimab. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Disease interactions
4 potential interactions Applies to: 4 conditions, including Liver Disease, Infection, Immunodeficiency, and Renal Dysfunction.
Immunodeficiency
Moderate:
Risa-Bid
The lactobacillus acidophilus in Risa-Bid has a moderate potential interaction with Immunodeficiency.
Probiotics, especially those containing lactobacillus, should be used with caution in immunosuppressed patients.
Infection
Moderate:
nipocalimab
Nipocalimab has a moderate potential interaction with Infection.
Nipocalimab may increase the risk of infection. Serious infections occurred in 7% of patients. Treatment with nipocalimab should be delayed in patients with an active infection until resolved. Nipocalimab may also reactivate latent viral infections, such as herpes zoster. Patients with positive hepatitis screening were excluded from clinical studies. Monitor patients closely for signs of infection during treatment. If serious infection occurs, withhold therapy and institute appropriate treatment, until the infection has resolved. Caution is advised in patients with latent viral infections.
Liver Disease
Moderate:
nipocalimab
Nipocalimab has a moderate potential interaction with Liver Disease.
Nipocalimab has not been studied in patients with severe liver and renal impairment.
Renal Dysfunction
Moderate:
nipocalimab
Nipocalimab has a moderate potential interaction with Renal Dysfunction.
Nipocalimab has not been studied in patients with severe liver and renal impairment.
Report options
More resources
nipocalimab
A total of 321 drugs are known to interact with nipocalimab.
- Nipocalimab is in the drug class selective immunosuppressants.
- Nipocalimab is used to treat the following conditions:
Risa-Bid
A total of 370 drugs are known to interact with Risa-Bid.
- Risa-bid is in the following drug classes: antidiarrheals, probiotics.
- Risa-bid is used to treat the following conditions:
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.